Discover our latest insights. 

On July 29, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ test, the first colorectal cancer screening test that analyzes a blood sample to identify molecular signs of cancer. The latest research shows that early detection of cancer improves treatment outcomes and survival rates and experts predict that having a non-invasive option will help to screen more patients and catch colorectal cancer at treatable stages.

During the warm months of spring and summer, the looming threat of ticks becomes more palpable. While most people are aware of Lyme disease as the primary concern, ticks carry a staggering array of 13 other diseases.

Alzheimer’s disease, the most common form of dementia in the United States, affects millions of Americans, predominately striking after the age of 60. However, there is a lesser-known rare variant of Alzheimer’s called Posterior Cortical Atrophy (PCA) that makes up about 5% of cases.

For the first time, the FDA has approved a treatment to reduce the severity of dangerous allergic reactions due to accidental exposure to food allergens. Here’s what to know about this new tool to help manage food allergies.

There have been a few COVID-19 updates in the news in the last month. It is important for people who are at high-risk of serious illness to be aware of these changes, including adults aged 65 years and older, pregnant people, children aged 5 years and under, and people with weakened immune systems due to medical conditions or immunosuppressive treatments.

At PHM, we advocate for a family-centered approach to care. Alongside our highly skilled advanced practice clinicians, PhD-led research scientists, and expert coordinators, we offer the support of Certified Child Life Specialists in-house. These specialists assist our clients in having difficult conversations with their children following a new cancer diagnosis and prepare them for what emotional or behavioral reactions they can expect.